Related Experiment Video

Updated: Nov 17, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.7K

Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by

Saray Porcar Saura1, Santiago Guillén Climent1, María Isabel Pinazo Canales1

  • 1Departments of Dermatology, and.

The American Journal of Dermatopathology
|February 17, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.1K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.1K

Related Experiment Videos

Last Updated: Nov 17, 2025

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

26.7K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.1K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.1K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

752
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
752
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
Neural Regulation01:37

Neural Regulation

41.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.7K

Articles linked to this work by shared authors, journal, and citation graph.

Superficial Pleomorphic Mesenchymal Tumors.

International journal of surgical pathology·2026

Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter Cohort.

Dermatology and therapy·2026

Evidence for Wnt/β-Catenin-Activated Rosette-Forming Carcinoma Arising in Rb-Inactivated Bowen Disease.

Journal of cutaneous pathology·2025

Eccrine Coil Elastosis: A New Dermatopathological Feature Associated With Prediabetes and Diabetes.

Journal of cutaneous pathology·2025

Epithelial elements in superficial angiomyxomas: mimicry of adnexal development, and mesenchymal-to-epithelial transition.

Histopathology·2025

The puzzling Spitz tumours: is artificial intelligence the key to their understanding?

Histopathology·2025

Histopathological Patterns in Bullous Dermatitis Artefacta: A Retrospective Case Series.

The American Journal of dermatopathology·2026

Quantitative Digital Image Analysis Detects Differences in Nuclear Features Between CK20-Negative and CK20-Positive Merkel Cell Carcinomas.

The American Journal of dermatopathology·2026

Congenital Adnexal Carcinoma with Cribriform Pattern in a Pediatric Patient.

The American Journal of dermatopathology·2026

Persistent Agmination of Lymphomatoid Papulosis with Features of Lymphomatoid Papulosis in Both the Regressing Papular Component and the Persistent Patch: A Case Report and Review of the Literature.

The American Journal of dermatopathology·2026

A Look Back at Mercury Soap as a Treatment for Yaws.

The American Journal of dermatopathology·2026

Histopathologic Comparison Between Morphea, Lichen Sclerosus, and Systemic Sclerosis: A Prospective Cross-Sectional Observational Study From a Tertiary Care Hospital.

The American Journal of dermatopathology·2026

Advancing Breast Cancer Diagnosis with Deep Layer-wise Feature Integration from Histopathology Images.

Journal of biomedical physics & engineering·2026

18F-AlF-NOTA-FAPI-04 PET/CT as a complementary tool for detecting occult signet-ring cell gastric adenocarcinoma when FDG imaging is inconclusive: a case report.

AME case reports·2026

Endobronchial Pulmonary Typical Carcinoid Tumors in Young Adults: A Three-Case Series Highlighting Obstructive Complications and Surgical Outcomes.

Cancer management and research·2026

Pulmonary malignant lymphoma requiring surgical lung biopsy for diagnosis following coronavirus disease 2019 infection: a case report.

AME case reports·2026

Artificial intelligence-based tongue image analysis for non-invasive screening of gastric cancer, precancerous lesions, and related gastrointestinal disorders: a systematic review.

Frontiers in medicine·2026

Identification of Crohn's disease-associated molecular signatures by integrative bioinformatics analysis and experimental validation.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us